» Articles » PMID: 7551381

Physiologic Effects of Nutritional Support and Anabolic Steroids in Patients with Chronic Obstructive Pulmonary Disease. A Placebo-controlled Randomized Trial

Overview
Specialty Critical Care
Date 1995 Oct 1
PMID 7551381
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Nutritional depletion commonly occurs in patients with COPD, causing muscle wasting and impaired physiologic function. Two hundred seventeen patients with COPD participated in a placebo-controlled, randomized trial investigating the physiologic effects of nutritional intervention alone (N) for 8 wk or combined with the anabolic steroid nandrolone decanoate (N + A). Nandrolone decanoate or placebo (P) was injected intramuscularly (women, 25 mg; men, 50 mg) in a double-blind fashion on Days 1, 15, 29, and 43. Nutritional intervention consisted of a daily high caloric supplement (420 kcal; 200 ml). Also, all patients participated in an exercise program. In the depleted patients, both treatment regimens induced a similar significant body weight gain (2.6 kg) but different body compositional changes. Particularly in the last 4 wk of treatment, weight gain in the N group was predominantly due to an expansion of fat mass (p < 0.03 versus P and N + A), whereas the relative changes in fat-free mass (FFM) and other measures of muscle mass were more favorable in the N + A group (p < 0.03 versus P). Maximal inspiratory mouth pressure improved within both treatment groups in the first 4 wk of treatment, but after 8 wk only N + A was significantly different from P (p < 0.03). Nutritional supplementation in combination with a short course of anabolic steroids may enhance the gain in FFM and respiratory muscle function in depleted patients with COPD without causing adverse side effects.

Citing Articles

Efficacy of nutrient supplements in managing malnutrition and sarcopenia in Chronic Obstructive Pulmonary Disease (COPD) patients: a protocol for systematic review and meta-analysis.

Zheng H, Zhang H, Wu K, Cai W, Li Z, Song X Syst Rev. 2025; 14(1):58.

PMID: 40069756 PMC: 11895150. DOI: 10.1186/s13643-025-02801-7.


Muscle growth and anabolism in intensive care survivors (GAINS 2.0): Protocol for a multi-centre randomised; placebo controlled clinical trial of nandrolone in deconditioned adults recovering from critical illness.

Anstey M, Litton E, Habibi M, Van der Lee L, Palmer R, Tran N PLoS One. 2025; 20(2):e0315170.

PMID: 39977382 PMC: 11841879. DOI: 10.1371/journal.pone.0315170.


Role of nutrition in patients with coexisting chronic obstructive pulmonary disease and sarcopenia.

Nan Y, Zhou Y, Dai Z, Yan T, Zhong P, Zhang F Front Nutr. 2023; 10:1214684.

PMID: 37614743 PMC: 10442553. DOI: 10.3389/fnut.2023.1214684.


Implementing an Evidence-Based COPD Hospital Discharge Protocol: A Narrative Review and Expert Recommendations.

Miravitlles M, Bhutani M, Hurst J, Franssen F, van Boven J, Khoo E Adv Ther. 2023; 40(10):4236-4263.

PMID: 37537515 PMC: 10499689. DOI: 10.1007/s12325-023-02609-8.


Efficacy of interventions to alter measures of fat-free mass in people with COPD: a systematic review and meta-analysis.

Jenkins A, Gaynor-Sodeifi K, Lewthwaite H, Triandafilou J, Belo L, de Oliveira M ERJ Open Res. 2023; 9(4).

PMID: 37529637 PMC: 10388177. DOI: 10.1183/23120541.00102-2023.